Colorado Therapeutics develops xenogeneic biologic tissue matrix products for soft tissue reinforcement, regenerative, and vascular applications.

This first-generation tenant finish buildout is for the research and production of tissue implants. The facility includes HVAC and power/data provisions to support the office, two clean rooms, chemical storage rooms, and processing areas.